Canandaigua National Bank & Trust Co. purchased a new stake in Encompass Health Corp (AMEX:EHC) during the first quarter, according to its most recent filing with the SEC. The fund purchased 6,290 shares of the company’s stock, valued at approximately $360,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in EHC. Cerebellum GP LLC bought a new stake in Encompass Health in the 4th quarter valued at $129,000. First Mercantile Trust Co. bought a new stake in Encompass Health in the 1st quarter valued at $142,000. O Shaughnessy Asset Management LLC bought a new stake in Encompass Health in the 1st quarter valued at $144,000. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Encompass Health in the 1st quarter valued at $219,000. Finally, Heartland Advisors Inc. bought a new stake in Encompass Health in the 4th quarter valued at $237,000. Institutional investors own 93.18% of the company’s stock.
In related news, insider Cheryl B. Levy sold 30,982 shares of Encompass Health stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $63.00, for a total transaction of $1,951,866.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Barbara Ann Jacobsmeyer sold 1,798 shares of Encompass Health stock in a transaction dated Monday, May 14th. The stock was sold at an average price of $62.73, for a total transaction of $112,788.54. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 69,777 shares of company stock valued at $4,326,032. 1.60% of the stock is owned by corporate insiders.
Shares of Encompass Health opened at $57.67 on Thursday, Marketbeat Ratings reports. Encompass Health Corp has a 52 week low of $40.86 and a 52 week high of $59.29. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34.
Encompass Health (AMEX:EHC) last issued its quarterly earnings data on Thursday, April 26th. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.81 by $0.12. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The business had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Encompass Health’s revenue was up 10.0% compared to the same quarter last year. equities research analysts predict that Encompass Health Corp will post 2.72 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, July 16th. Investors of record on Monday, July 2nd will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, June 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.73%.
A number of analysts have issued reports on the stock. Credit Suisse Group lifted their price target on shares of Encompass Health from $65.00 to $66.00 and gave the company an “outperform” rating in a report on Friday, April 27th. Robert W. Baird reiterated an “outperform” rating and issued a $66.00 price target (up from $59.00) on shares of Encompass Health in a report on Monday, April 30th. Craig Hallum reissued a “buy” rating and issued a $71.00 price objective (up from $63.00) on shares of Encompass Health in a research note on Monday, April 30th. SunTrust Banks reissued a “buy” rating and issued a $70.00 price objective on shares of Encompass Health in a research note on Tuesday, April 17th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $59.00 price objective on shares of Encompass Health in a research note on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company. Encompass Health has a consensus rating of “Buy” and an average target price of $64.10.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.